We are committed to responsible and sustainable operations, recognising that our actions affect our stakeholders and the communities we serve. This spans across patient health, employee health, community health, environmental health and global public health.

We believe in supporting patients with more than our medicines alone. Initiatives include:

MyEpiPen^® patient support program
Australia has the largest program globally with over 40,000 members. The program includes reminders to prompt patients to get a new prescription, a free trainer device, “how to use” cards to keep at home and share with friends and family and video explainers in 25 languages.

Ferro-grad resource kit
Patients who are starting on our iron supplement Ferro-grad for iron deficiency are provided with with a resource kit which includes patient support materials and education to help them understand and manage their condition.

Supporting cancer research
Together with the QIMR Berghofer Medical Research Institute, Viatris supports research to assist with the earlier diagnosis and treatment of panreatic cancer.

We are committed to environmentally responsible conduct and have policies and procedures to systematically minimise our environmental footprint. Our integrated, comprehensive approach focuses on managing our water, air emissions, waste, climate change and energy impact. Ninety-five per cent of pharmaceutical waste has been diverted from landfills to incineration or energy recovery facilities.